Company Data
ReShape Lifesciences Inc.
Ticker
RSLS
Current Price
$4.91 8.15%
Market Cap
$3.6M
Price Target
Refer to Report
Volume
73.9K
52wk Range
$4.3436 - $725
Overview
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company’s current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app.